DOW JONES22,327.48+690.70 3.19%
S&P 5002,626.65+85.18 3.35%
NASDAQ7,774.15+271.77 3.62%

PLx Pharma Q4 Adj. EPS $(0.45) Beats $(0.48) Estimate, Sales $24K Beat $10K Estimate

PLx Pharma (NASDAQ:PLXP) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.48) by 6.25 percent. This is a 45.16 percent decrease over losses of $(0.31) per share from the

Benzinga · 03/13/2020 10:52

PLx Pharma (NASDAQ:PLXP) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.48) by 6.25 percent. This is a 45.16 percent decrease over losses of $(0.31) per share from the same period last year. The company reported quarterly sales of $24 thousand which beat the analyst consensus estimate of $10 thousand by 140.00 percent. This is a 91.66 percent decrease over sales of $287.662 thousand the same period last year.